Company: ARTL
Filing Date: 2025-11-17
Form Type: S-1
Source: 0001640334-25-002154
Chunk: 33

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-17
Form: S-1
Chunk 33
---
 Common Stock issuable upon exercise of the $3.40 Warrants and (iv) 2,278 shares of Common Stock issuable pursuant to options held directly by Tamara A. Favorito exercisable within 60 days of November 10, 2025. |
| (8) | Consists of 1,562 shares of Common Stock issuable pursuant to options held directly by Mark Spring exercisable within 60 days of November 10, 2025                                                                                                                                                                                                                                                           |
| (9) | Includes 68,843 shares of Common Stock subject to options exercisable within 60 days of November 10, 2025.                                                                                                                                                                                                                                                                                                   |

| 22 |

<div align='center'>DESCRIPTION OF CAPITAL STOCK</div>

The following description summarizes certain terms of our capital stock and certain provisions of our Articles of Incorporation and Bylaws. This summary does not purport to be complete and is qualified in its entirety by the provisions of our Articles of Incorporation and Bylaws, copies of which are filed with the SEC as exhibits to the registration statement on Form S-1 of which this prospectus forms a part, and to the applicable provisions of Nevada law.

Authorized Capital Stock

Our authorized capital stock consists of 500,069,445 shares of capital stock, of which 500,000,000 shares are designated as common stock, $0.001 par value per share, and 69,445 shares are designated as preferred stock, $0.001 par value per share. As of November 10, 2025, there were 2,018,746 shares of Common Stock issued and outstanding held by approximately 166 holders of record of our Common Stock, and no outstanding shares of preferred stock.

Common Stock

The holders of our Common Stock (i) have equal ratable rights to dividends from funds legally available therefor, when, as and if declared by our board of directors; (ii) are entitled to share in all of our assets available for distribution to holders of Common Stock upon liquidation, dissolution or winding up of our affairs; (iii) do not have preemptive, subscription or conversion rights and there are no redemption or sinking fund provisions or rights; and (iv) are entitled to one non-cumulative vote per share on all matters submitted to a vote of stockholders. The rights, preferences and privileges of the holders of our Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we